spacer
home > pmps > winter 2002 > acrylic finishes wipe the floor in hygiene stakes
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Acrylic Finishes Wipe the Floor in Hygiene Stakes

This article discusses how a new generation of acrylic flooring has advantages over its rivals for cleanroom environments. The concept of cleanroom environments to control the spread of infectious diseases first emerged more than 100 years ago and was developed by hospitals in Victorian times. Over the last 20 years the demand for contamination control has increased to such an extent that some cleanrooms are so specialised they need to be a thousand times cleaner than those designed in the past.

Pharmaceutical and biotechnology industries benefit greatly from tight contamination control, particularly when considering that a few grams of product can be worth thousands of pounds and no company can afford potential losses. Even the slightest contamination can spell disaster as companies strive for completely sterile environments and, in an age where standards for health and safety become ever stricter, anything additional that boosts the quality of a cleanroom environment is to be welcomed. Such sterile conditions can help lead to higher productivity, fewer rejects, lower utility costs and greater confidence in the final product.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Tony Blackman, Technical Manager of Acrylicon East
Tony Blackman is currently Technical Manager of Acrylicon's Eastern Division. Tony has an in-depth knowledge of the industrial flooring market, having run his own contracting business for more than 20 years.

He is experienced in the use of polyurethanes, epoxys and acrylic systems and has worked for companies such as Heathrow Airport and Courage Brewery.

spacer
Tony Blackman
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

MedPharm’s CSO and University of Reading Professor co-author new book on dermal formulation development

MedPharm’s Chief Scientific Officer and Co-Founder, Professor Marc Brown and University of Reading’s Professor Adrian Williams have co-authored the new book: ‘The Art and Science of Dermal Formulation Development”. It is the latest addition to ‘Drugs and the Pharmaceutical Sciences’, a series of textbooks and monographs published by CRC Press.
More info >>

White Papers

pAVEway™ expression system for the efficient expression of therapeutic proteins

Fujifilm Diosynth Biotechnologies

One of the major bottlenecks in the production of biopharmaceuticals is the efficient expression of therapeutic proteins in microbial or mammalian cells. The Escherichia coli pAVEway™ expression system described here has been developed to ensure high product titres and efficient scale up to GMP manufacture, whilst minimising many common issues seen in other expression systems, such as ‘leaky’ expression (expression of recombinant protein in the absence of inducer).
More info >>

 
Industry Events

DIA 2019 Global Annual Meeting

23-27 June 2019, San Diego Convention Center

DIA 2019 is more than just a meeting: it’s where brilliant minds come together to create solutions. Thousands of global innovators will convene to engage in discussions on today’s hottest topics in the life sciences field, propose ways to combat daily challenges, and network to create lasting connections.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement